DZ2933A1 - Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant. - Google Patents

Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant.

Info

Publication number: DZ2933A1
Authority: DZ; Algeria
Prior art keywords: azabicydilic; benzisoxazole; ethyl; substituted; compounds
Prior art date: 1998-12-28

Application number

DZ990233A

Other languages

English (en)

Inventor

Gene Michael Bright

Kishor Amratlal Desai

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-28

Filing date

1999-11-10

Publication date

2004-03-15

1999-11-10 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DZ2933A1 publication Critical patent/DZ2933A1/fr

Links

150000001875 compounds Chemical class 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Addiction (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Dermatology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DZ990233A 1998-12-28 1999-11-10 Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant. DZ2933A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11395798P	1998-12-28	1998-12-28

Publications (1)

Publication Number	Publication Date
DZ2933A1 true DZ2933A1 (fr)	2004-03-15

Family

ID=22352526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990233A DZ2933A1 (fr)	1998-12-28	1999-11-10	Nouveaux composés azabicydilques à substitution hétéroaryl-éthyle/benzisoxazole, leur procédé de production et composition pharmaceutique les contenant.

Country Status (43)

Country	Link
US (1)	US6525196B1 (fr)
EP (1)	EP1140931B1 (fr)
JP (1)	JP2002533463A (fr)
KR (1)	KR100417506B1 (fr)
CN (1)	CN1332740A (fr)
AP (1)	AP2001002188A0 (fr)
AR (1)	AR024840A1 (fr)
AT (1)	ATE260278T1 (fr)
AU (1)	AU761711B2 (fr)
BG (1)	BG105710A (fr)
BR (1)	BR9916807A (fr)
CA (1)	CA2356985C (fr)
CO (1)	CO5150179A1 (fr)
CR (1)	CR6398A (fr)
CZ (1)	CZ291163B6 (fr)
DE (1)	DE69915113T2 (fr)
DK (1)	DK1140931T3 (fr)
DZ (1)	DZ2933A1 (fr)
EA (1)	EA003099B1 (fr)
EE (1)	EE04439B1 (fr)
ES (1)	ES2214892T3 (fr)
GE (1)	GEP20043227B (fr)
GT (1)	GT199900224A (fr)
HR (1)	HRP20010488A2 (fr)
HU (1)	HUP0104852A3 (fr)
ID (1)	ID30117A (fr)
IL (1)	IL143385A0 (fr)
IS (1)	IS5951A (fr)
MA (1)	MA26706A1 (fr)
NO (1)	NO20013215L (fr)
NZ (1)	NZ511964A (fr)
OA (1)	OA11742A (fr)
PA (1)	PA8486701A1 (fr)
PE (1)	PE20001234A1 (fr)
PT (1)	PT1140931E (fr)
SK (1)	SK9002001A3 (fr)
TN (1)	TNSN99218A1 (fr)
TR (1)	TR200101979T2 (fr)
TW (1)	TW523514B (fr)
UA (1)	UA62015C2 (fr)
WO (1)	WO2000039128A1 (fr)
YU (1)	YU44301A (fr)
ZA (1)	ZA200105041B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003065970A2 (fr) *	2001-02-20	2003-08-14	Royal College Of Surgeons Ie	Traitement de la fibromyalgie et du syndrome de fatigue associe au moyen d'antagonistes ou d'agonistes partiels de recepteurs 5ht1a
GB0203778D0 (en) *	2002-02-18	2002-04-03	Glaxo Group Ltd	Compounds
AP2005003390A0 (en) *	2003-03-12	2005-09-30	Pfizer Prod Inc	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives.
GB0316915D0 (en) *	2003-07-18	2003-08-20	Glaxo Group Ltd	Compounds
WO2005082370A1 (fr) *	2004-01-29	2005-09-09	Pfizer Products Inc.	Combinaisons d'un antipsychotique atypique et de derives azabicycliques d'aminomethylpyridyloxy- methyle/benzisoxazole pour le traitement de troubles du systeme nerveux central
AR048112A1 (es) *	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
AR049478A1 (es)	2004-03-25	2006-08-09	Solvay Pharm Bv	Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
BRPI0515143A (pt) *	2004-09-10	2008-07-08	Pfizer Prod Inc	usos de derivados azabicìclicos de piridiloximetila e benzisoxazol para a preparação de uma composição farmacêutica para o tratamento dos distúrbios de humor
JP2008512441A (ja) *	2004-09-10	2008-04-24	ファイザー・プロダクツ・インク	ピリジルオキシメチル、及びベンズイソオキサゾール・アザビシクロ誘導体を使用する、認知障害の治療方法
DE102005026194A1 (de) *	2005-06-06	2006-12-07	Grünenthal GmbH	Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
WO2008019431A1 (fr) *	2006-08-14	2008-02-21	Brc Operations Pty Limited	Procédé et compositions pour réguler simultanément la mémoire et l'humeur
WO2014078568A1 (fr)	2012-11-14	2014-05-22	The Johns Hopkins University	Méthodes et compositions pour le traitement de la schizophrénie
WO2020183011A1 (fr)	2019-03-14	2020-09-17	Institut Curie	Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer
WO2021127391A1 (fr) *	2019-12-20	2021-06-24	The Jackson Laboratory	Cibles moléculaires pour la dépendance

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5157034A (en) *	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
US5756496A (en) *	1994-05-28	1998-05-26	Smithkline Beecham P.L.C.	Amide derivatives having 5HT1D-antagonist activity
IL132409A0 (en) *	1997-04-18	2001-03-19	Smithkline Beecham Plc	Indole derivatives having combined 5ht1a 5ht1b and 5ht1d receptor antagonist activity
IT1293807B1 (it) *	1997-08-01	1999-03-10	Recordati Chem Pharm	Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
PA8469101A1 (es) *	1998-04-09	2000-09-29	Pfizer Prod Inc	Ligandos azabiciclicos de receptores 5ht1

1999
- 1999-03-11 UA UA2001064492A patent/UA62015C2/uk unknown
- 1999-04-11 AR ARP990105589A patent/AR024840A1/es unknown
- 1999-11-03 YU YU44301A patent/YU44301A/sh unknown
- 1999-11-03 AP APAP/P/2001/002188A patent/AP2001002188A0/en unknown
- 1999-11-03 AT AT99951040T patent/ATE260278T1/de not_active IP Right Cessation
- 1999-11-03 NZ NZ511964A patent/NZ511964A/en unknown
- 1999-11-03 CZ CZ20012386A patent/CZ291163B6/cs not_active IP Right Cessation
- 1999-11-03 DK DK99951040T patent/DK1140931T3/da active
- 1999-11-03 ID IDW00200101401A patent/ID30117A/id unknown
- 1999-11-03 JP JP2000591039A patent/JP2002533463A/ja active Pending
- 1999-11-03 OA OA1200100172A patent/OA11742A/en unknown
- 1999-11-03 DE DE69915113T patent/DE69915113T2/de not_active Expired - Fee Related
- 1999-11-03 CN CN99815202A patent/CN1332740A/zh active Pending
- 1999-11-03 EE EEP200100346A patent/EE04439B1/xx not_active IP Right Cessation
- 1999-11-03 PT PT99951040T patent/PT1140931E/pt unknown
- 1999-11-03 SK SK900-2001A patent/SK9002001A3/sk unknown
- 1999-11-03 EA EA200100517A patent/EA003099B1/ru not_active IP Right Cessation
- 1999-11-03 TR TR2001/01979T patent/TR200101979T2/xx unknown
- 1999-11-03 GE GEAP19995963A patent/GEP20043227B/en unknown
- 1999-11-03 IL IL14338599A patent/IL143385A0/xx unknown
- 1999-11-03 BR BR9916807-3A patent/BR9916807A/pt not_active Application Discontinuation
- 1999-11-03 WO PCT/IB1999/001772 patent/WO2000039128A1/fr not_active Ceased
- 1999-11-03 CA CA002356985A patent/CA2356985C/fr not_active Expired - Fee Related
- 1999-11-03 HU HU0104852A patent/HUP0104852A3/hu unknown
- 1999-11-03 KR KR10-2001-7008261A patent/KR100417506B1/ko not_active Expired - Fee Related
- 1999-11-03 AU AU63614/99A patent/AU761711B2/en not_active Ceased
- 1999-11-03 ES ES99951040T patent/ES2214892T3/es not_active Expired - Lifetime
- 1999-11-03 HR HR20010488A patent/HRP20010488A2/hr not_active Application Discontinuation
- 1999-11-03 EP EP99951040A patent/EP1140931B1/fr not_active Expired - Lifetime
- 1999-11-04 PE PE1999001116A patent/PE20001234A1/es not_active Application Discontinuation
- 1999-11-05 TW TW088119374A patent/TW523514B/zh not_active IP Right Cessation
- 1999-11-10 DZ DZ990233A patent/DZ2933A1/fr active
- 1999-11-10 MA MA25844A patent/MA26706A1/fr unknown
- 1999-11-17 TN TNTNSN99218A patent/TNSN99218A1/fr unknown
- 1999-11-18 CO CO99072703A patent/CO5150179A1/es unknown
- 1999-12-06 US US09/454,509 patent/US6525196B1/en not_active Expired - Fee Related
- 1999-12-07 PA PA19998486701A patent/PA8486701A1/es unknown
- 1999-12-23 GT GT199900224A patent/GT199900224A/es unknown
2001
- 2001-05-22 IS IS5951A patent/IS5951A/is unknown
- 2001-06-19 CR CR6398A patent/CR6398A/es not_active Application Discontinuation
- 2001-06-20 ZA ZA200105041A patent/ZA200105041B/en unknown
- 2001-06-27 NO NO20013215A patent/NO20013215L/no not_active Application Discontinuation
- 2001-07-16 BG BG105710A patent/BG105710A/xx unknown

Also Published As

Publication number	Publication date
ATE260278T1 (de)	2004-03-15
GT199900224A (es)	2001-06-15
HRP20010488A2 (en)	2002-08-31
YU44301A (sh)	2004-07-15
DE69915113T2 (de)	2004-08-26
OA11742A (en)	2005-05-13
PT1140931E (pt)	2004-05-31
DE69915113D1 (de)	2004-04-01
EE04439B1 (et)	2005-02-15
IL143385A0 (en)	2002-04-21
BG105710A (en)	2002-02-28
TNSN99218A1 (fr)	2005-11-10
GEP20043227B (en)	2004-04-26
BR9916807A (pt)	2001-10-23
HUP0104852A3 (en)	2002-12-28
NO20013215L (no)	2001-08-27
CR6398A (es)	2004-03-24
PE20001234A1 (es)	2000-11-07
CZ20012386A3 (cs)	2002-02-13
HUP0104852A2 (hu)	2002-05-29
CZ291163B6 (cs)	2003-01-15
AU6361499A (en)	2000-07-31
US6525196B1 (en)	2003-02-25
PA8486701A1 (es)	2000-09-29
EA200100517A1 (ru)	2001-12-24
WO2000039128A1 (fr)	2000-07-06
KR100417506B1 (ko)	2004-02-05
SK9002001A3 (en)	2002-04-04
CO5150179A1 (es)	2002-04-29
AP2001002188A0 (en)	2001-06-30
CA2356985C (fr)	2006-08-08
EP1140931A1 (fr)	2001-10-10
NZ511964A (en)	2003-08-29
AU761711B2 (en)	2003-06-05
EA003099B1 (ru)	2002-12-26
DK1140931T3 (da)	2004-04-19
CN1332740A (zh)	2002-01-23
TR200101979T2 (tr)	2001-12-21
NO20013215D0 (no)	2001-06-27
EP1140931B1 (fr)	2004-02-25
UA62015C2 (en)	2003-12-15
ES2214892T3 (es)	2004-09-16
IS5951A (is)	2001-05-22
KR20010092455A (ko)	2001-10-25
CA2356985A1 (fr)	2000-07-06
ZA200105041B (en)	2002-06-20
TW523514B (en)	2003-03-11
AR024840A1 (es)	2002-10-30
ID30117A (id)	2001-11-08
MA26706A1 (fr)	2004-12-20
JP2002533463A (ja)	2002-10-08
EE200100346A (et)	2002-12-16

Publication	Publication Date	Title
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26463A1 (fr)	2004-12-20	Nouvelles sulfones cycliques, leur procede de production et composition pharmaceutique les contenant
DZ2889A1 (fr)	2003-12-15	4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2395A1 (fr)	2003-06-04	Composés nouveaux a noyau dibenzocycloheptène procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2697A1 (fr)	2003-03-29	Composés azapolycycliques à noyau aryle condensé procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3000A1 (fr)	2004-03-27	Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.
MA24529A1 (fr)	1998-12-31	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
DZ2944A1 (fr)	2004-03-15	Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.
DZ3052A1 (fr)	2004-03-27	Composés nouveaux inhibiteurs de métalloprotéases,procédé pour leur préparation et compositions pha rmaceutiques les contenant.
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2753A1 (fr)	2005-09-15	Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
MA26558A1 (fr)	2004-12-20	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2567131B1 (fr)	1991-06-07	Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26551A1 (fr)	2004-12-20	Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2729A1 (fr)	2005-03-01	Composés nouveaux inhibiteurs de nhe-1 procédé pour leur préparation et compositions pharmaceutiquesles contenant.
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26642A1 (fr)	2004-12-20	Derives de sulfonylbenzene nouveaux, procédé pour leur preparation et compositions pharmaceutiques les contenant.
DZ2751A1 (fr)	2003-09-15	Composés calciolytiques nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
MA26624A1 (fr)	2004-12-20	Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2655A1 (fr)	2003-03-22	Trifluorométhyléthers cycliques à fonction pipéridinylaminoéthyle procédé pour leur préparation et compositions pharmaceutiques les contenant.